HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Ashton Selected Research

Artesunate

12/2014Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Ashton Research Topics

Disease

10Falciparum Malaria (Plasmodium falciparum Malaria)
01/2018 - 04/2002
7Malaria
01/2018 - 04/2002
6Tuberculosis (Tuberculoses)
10/2022 - 11/2013
4African Trypanosomiasis (Nagana)
01/2022 - 01/2011
4Infections
01/2020 - 02/2016
4Acquired Immunodeficiency Syndrome (AIDS)
11/2013 - 04/2008
2Mental Disorders (Mental Disorder)
10/2023 - 12/2022
2Neglected Diseases
01/2022 - 01/2021
1Trichomonas Infections
07/2022
1Anaphylaxis (Anaphylactic Shock)
07/2022
1Immediate Hypersensitivity
07/2022
1Pruritus (Itching)
07/2022
1Urticaria (Hives)
07/2022
1Parasitic Diseases (Parasitic Disease)
09/2020
1Breast Neoplasms (Breast Cancer)
12/2014
1Drug-Related Side Effects and Adverse Reactions
02/2014
1Chronic Renal Insufficiency
05/2004

Drug/Important Bio-Agent (IBA)

6artemisinin (artemisinine)IBA
02/2016 - 04/2002
5efavirenz (Sustiva)FDA Link
02/2014 - 04/2008
4Eflornithine (Ornidyl)FDA Link
01/2022 - 01/2011
4artenimol (dihydroartemisinin)IBA
01/2018 - 08/2008
4piperaquineIBA
02/2016 - 08/2008
3Rifampin (Rifampicin)FDA LinkGeneric
10/2022 - 01/2019
3Isoniazid (Ftivazide)FDA LinkGeneric
10/2022 - 01/2019
3ArtemetherFDA Link
01/2018 - 11/2010
3LumefantrineFDA Link
07/2017 - 11/2010
2Hallucinogens (Psychedelics)IBA
10/2023 - 12/2022
2N,N-Dimethyltryptamine (Dimethyltryptamine)IBA
10/2023 - 12/2022
2PyrazinamideFDA LinkGeneric
01/2021 - 01/2019
2Ethambutol (Myambutol)FDA LinkGeneric
01/2020 - 01/2019
2Cytochrome P-450 CYP2B6 (CYP2B6)IBA
02/2014 - 04/2008
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2014 - 08/2011
14-nitroimidazoleIBA
07/2022
1Immunoglobulin E (IgE)IBA
07/2022
1Metronidazole (Metric)FDA LinkGeneric
07/2022
1TinidazoleFDA Link
07/2022
1pyrazinoic acidIBA
01/2021
15-hydroxypyrazinamideIBA
01/2021
1PolyaminesIBA
01/2021
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2020
1Isonicotinic Acids (Isonicotinic Acid)IBA
01/2020
1Antitubercular AgentsIBA
01/2019
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
01/2018
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2017
1ArtesunateIBA
12/2014
1EnzymesIBA
02/2014
1Urea (Carbamide)FDA LinkGeneric
08/2011
1Adenosine Triphosphate (ATP)IBA
08/2011
1Alanine Transaminase (SGPT)IBA
08/2011
1CreatinineIBA
08/2011
1Cytochrome P-450 CYP3AIBA
08/2011
1Amodiaquine (Camoquin)FDA Link
10/2007
1desethylamodiaquineIBA
10/2007
1candesartan cilexetil (Amias)FDA Link
05/2004
1Angiotensin Receptor AntagonistsIBA
05/2004
1Antiparasitic Agents (Antiparasitics)IBA
08/2002
1Mefloquine (Lariam)FDA LinkGeneric
08/2002
1Antimalarials (Antimalarial Agents)IBA
08/2002

Therapy/Procedure

5Therapeutics
01/2022 - 05/2004
2Oral Administration
12/2014 - 08/2011